FSIS is holding a public meeting and open comment period under Docket No. FSIS-2025-0179 to gather stakeholder input on future strategies to reduce Salmonella illnesses associated with poultry products. This follows the withdrawal of FSIS's earlier proposed Salmonella framework, and the agency is now seeking feedback on alternative policy approaches, data use, performance measures, and practical implementation considerations.
FSIS has specifically invited comments on:
- How data should be used to drive Salmonella reduction strategies
- Potential performance standards or control approaches
- Ways to improve public health outcomes without unintended consequences
- Practical impacts on establishments, including our small and very small processors
Before submitting my own thoughts and comments, I'm interested in hearing your perspectives/insights.
For context, the previous withdrawn proposal suggested (v simplified):
- Adulteration determinations would be based on Salmonella levels and serotypes
- Serotypes of concern (specific strains would carry more penalty)
- Enhanced process monitoring (more frequency w/ additional required locations like rehang and post-chill)
Are there gaps or ambiguities in current FSIS/FDA guidance that should be addressed?
I appreciate any insights as I shape my own comments for the docket. Wishing everyone well during the holiday season :)









